The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Nippon Express has provided a pharmaceutical distribution platform with strict temperature control in two ranges -- 2 C to 8 C
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
Subscribe To Our Newsletter & Stay Updated
